Hebrew University of Jerusalem scientists have developed a molecule to treat glioblastoma, a very aggressive type of brain cancer. The molecule blocks the ability of the MKNK2 gene to produce Mnk2b – a cancer-causing protein but increases the levels of Mnk2a – an inhibitor protein.

http://www.xinhuanet.com/english/2018-10/31/c_137572222.htm